Showing results (41-50 of 195) with videos related to

Sort By:
Pageof 20
Chest|October 11, 2007
The 6-min walk distance, peak oxygen uptake, and mortality in COPDClaudia G Cote, Victor Pinto-Plata, Kyra Kasprzyk, et al.
Clinical Therapeutics|May 17, 2003
A comparison of 5-day courses of dirithromycin and azithromycin in the treatment of acute exacerbations of chronic obstructive pulmonary diseaseRichard S Castaldo, Bartolome R Celli, Fernando Gomez, et al.
Chest|July 11, 2003
Muscle strength and exercise kinetics in COPD patients with a normal fat-free mass index are comparable to control subjectsYvonne F Heijdra, Victor Pinto-Plata, Regina Frants, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|September 5, 2019
Exacerbations, Health Resource Utilization, and Costs Among Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease Treated with Nebulized Arformoterol Following a Respiratory EventMaryam Navaie, Bartolome R Celli, Zhun Xu, et al.
Respiratory Care|August 8, 2020
Methods for a Seamless Transition From Tracheostomy to Spontaneous Breathing in Patients With COVID-19Miguel J Divo, Catherine L Oberg, Michael A Pritchett, et al.
The European Respiratory Journal|September 7, 2023
From pre-COPD to COPD: a Simple, Low cost and easy to IMplement (SLIM) risk calculatorMiguel J Divo, Congjian Liu, Francesca Polverino, et al.
Respiratory Research|January 22, 2020
Metabolic and cardiorespiratory effects of decreasing lung hyperinflation with budesonide/formoterol in COPD: a randomized, double-crossover, placebo-controlled, multicenter trialMiguel J Divo, Michael R DePietro, John R Horton, et al.
COPD|June 20, 2019
Predictors of Nebulized Arformoterol Treatment: A Retrospective Analysis of Medicare Beneficiaries with Chronic Obstructive Pulmonary DiseaseTodd P Gilmer, Bartolome R Celli, Zhun Xu, et al.
Chest|May 15, 2002
Cough and phlegm are important predictors of health status in smokers without COPDYvonne F Heijdra, Victor M Pinto-Plata, Lawrence A Kenney, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 14, 2019
Medication management patterns among Medicare beneficiaries with chronic obstructive pulmonary disease who initiate nebulized arformoterol treatmentBartolome R Celli, Maryam Navaie, Zhun Xu, et al.
Pageof 20